comparemela.com
Home
Live Updates
FDA advisors scrutiny of MDMA therapy is temporary setback, says Harvard researcher : comparemela.com
FDA advisors' scrutiny of MDMA therapy is 'temporary setback,' says Harvard researcher
Some Boston-area researchers said the decision by advisors to the U.S. Food and Drug Administration reflected challenges facing regulators as psychedelic treatments enter mainstream psychiatry.
Related Keywords
Boston ,
Massachusetts ,
United States ,
Stephen Haggarty ,
Deborah Becker ,
Harvard Law School Petrie Flom Center ,
Drug Administration ,
Hospital Center ,
Some Boston Area ,
Lykos Therapeutics ,
Mass General Hospital ,
Mason Marks ,
Psychedelics Law ,
Harvard Law School ,
Petrie Flom Center ,
All Things Considered ,
comparemela.com © 2020. All Rights Reserved.